BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3511406)

  • 1. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases].
    Sinforiani E; Trucco M; Pacchetti C; Gualtieri S
    Minerva Med; 1986 Jan; 77(1-2):51-7. PubMed ID: 3511406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of citicoline in the study of chronic cerebrovascular diseases].
    Grasso A; Ventimiglia A; Sofia V; Arena M; Campo G
    Minerva Med; 1988 Sep; 79(9):791-6. PubMed ID: 2902537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy].
    Rossi M; Zanardi M
    Clin Ter; 1993 Feb; 142(2):141-4. PubMed ID: 8472528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
    De Gregorio G; Armeli G; Restivo S; Francolino A
    Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
    [No Abstract]   [Full Text] [Related]  

  • 5. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathological aging of the brain. Personal observations on the use of citicoline].
    Palleschi M; Capobianco G
    Clin Ter; 1988 Apr; 125(2):121-8. PubMed ID: 2973933
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
    Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
    Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial.
    Iranmanesh F; Vakilian A
    J Stroke Cerebrovasc Dis; 2008; 17(3):153-5. PubMed ID: 18436157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Agentss to improve cerebrovascular circulation and cerebral metabolism--citicoline].
    Miyazaki M
    Nihon Rinsho; 1985 Feb; 43(2):372-5. PubMed ID: 3999407
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuropsychological study of the senile brain during and after single and combined treatment with deanol and citicoline].
    Bonavita E
    Clin Ter; 1986 Jun; 117(5):387-98. PubMed ID: 3742961
    [No Abstract]   [Full Text] [Related]  

  • 14. [CDP choline and cerebrovascular insufficiency in the elderly. Clinical study of 40 patients undergoing prolonged treatment].
    Merchan C; Berchicci R; Cuzzoni G; Pecorini M
    Minerva Cardioangiol; 1985 Mar; 33(3):145-8. PubMed ID: 4010981
    [No Abstract]   [Full Text] [Related]  

  • 15. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The current state of citicholine in cerebral ischemia].
    Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
    Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the effect of CDP in patients with motor disorders of cerebral origin].
    Asirón Yribarren PJ; Bascuas Asta JL; Marín Górriz F; Marín Redondo J; Noguera Lobera AR; Ramos Cristóbal JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(1):97-104. PubMed ID: 654990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of citicoline in high dosages in acute cerebrovascular disease].
    Centrone G; Ragno G; Calicchio G
    Minerva Med; 1986 Mar; 77(11):371-3. PubMed ID: 3703329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M; Magnani G; Sinforiani E; Casali R
    Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.